These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6437706)

  • 41. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man.
    Thorner MO; Rivier J; Spiess J; Borges JL; Vance ML; Bloom SR; Rogol AD; Cronin MJ; Kaiser DL; Evans WS; Webster JD; MacLeod RM; Vale W
    Lancet; 1983 Jan; 1(8314-5):24-8. PubMed ID: 6129370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intravenous administration of growth hormone-releasing factor (hpGRF-44) and Tyr-D-Trp-Ala-Trp-D-Phe-NH2 on plasma hormones and metabolites in goats.
    Hart IC; James S; Perry BN; Simmonds AD
    J Endocrinol; 1984 Nov; 103(2):173-8. PubMed ID: 6436424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma growth hormone secretion during constant growth hormone-releasing factor infusion.
    Takano K; Hizuka N; Shizume K; Hirose N; Ling N
    Endocrinol Jpn; 1984 Dec; 31(6):681-5. PubMed ID: 6442696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
    Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):129-35. PubMed ID: 1934527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human pancreas GH-releasing factor analog restores high-amplitude GH pulses in CNS lesion-induced GH deficiency.
    Tannenbaum GS; Eikelboom R; Ling N
    Endocrinology; 1983 Sep; 113(3):1173-5. PubMed ID: 6409591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
    Kopelman PG; Noonan K; Goulton R; Forrest AJ
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma growth hormone (GH) responses to growth hormone releasing factor (hp GRF 1-44) in familial GH deficiency.
    Kibirige MS; Price DA; Shalet SM; Bailie GR
    Acta Paediatr Scand; 1987 Jan; 76(1):103-6. PubMed ID: 3105240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.
    Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF
    Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats.
    Clark RG; Robinson IC
    J Endocrinol; 1985 Sep; 106(3):281-9. PubMed ID: 2864380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma GH response to hpGRF-44 in normal children of short stature and patients with GH deficiency.
    Takano K; Hizuka N; Shizume K; Ling NC
    Endocrinol Jpn; 1984 Feb; 31(1):41-8. PubMed ID: 6428864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Administration of synthetic human pancreatic growth hormone-releasing factor for five days sustains raised serum concentrations of growth hormone in steers.
    Moseley WM; Krabill LF; Friedman AR; Olsen RF
    J Endocrinol; 1985 Mar; 104(3):433-9. PubMed ID: 3919137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential responsiveness of the somatotroph to growth hormone-releasing factor during early neonatal development in the rat.
    Szabo M; Cuttler L
    Endocrinology; 1986 Jan; 118(1):69-73. PubMed ID: 3000750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma growth hormone, somatostatin, insulin and glucagon inter-relationships during infusion of human pancreatic growth hormone-releasing factor in young and adult ducks (Anas platyrhynchos).
    Foltzer-Jourdainne C; Harvey S; Karmann H; Mialhe P
    J Endocrinol; 1987 Jul; 114(1):25-32. PubMed ID: 2888829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential uses of human pancreatic growth hormone-releasing factor 1-44 amide.
    Belchetz PE; Weldon SF; Davis JC; Diver MJ; Smith CS; Harris F
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):201-8. PubMed ID: 6432378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.